A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers
Clinical trial NCT03356561 · COMPLETED
Trial details
- NCT number
- NCT03356561
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-26
- Primary completion
- 2019-09-23
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.